Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 1,277 -0.79%
19 Jun - close price
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 14,540 Cr.
  • Current Price ₹ 1,277
  • High / Low ₹ 1,415 / 1,045
  • Stock P/E 90.1
  • Book Value ₹ 284
  • Dividend Yield 0.06 %
  • ROCE 6.95 %
  • ROE 5.34 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company's median sales growth is 19.2% of last 10 years
  • Company's working capital requirements have reduced from 168 days to 125 days

Cons

  • Stock is trading at 4.49 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 4.17% over last 3 years.
  • Dividend payout has been low at 11.2% of profits over last 3 years
  • Company has high debtors of 200 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of Nifty 500 Nifty MidSmallcap 400 Nifty Smallcap 250 Nifty 500 Multicap 50:25:25 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
371 288 317 215 308 164 191 212 331 316 588 401 371
279 210 226 151 235 127 139 140 225 221 479 301 270
Operating Profit 92 78 91 64 74 37 52 72 106 94 109 101 101
OPM % 25% 27% 29% 30% 24% 22% 27% 34% 32% 30% 19% 25% 27%
18 10 4 1 11 6 4 -3 5 5 8 5 2
Interest 20 18 20 25 25 22 25 30 29 34 35 34 37
Depreciation 17 17 18 18 18 19 20 26 27 26 28 29 31
Profit before tax 74 54 57 22 42 2 11 13 55 39 55 43 35
Tax % 30% 35% 32% 29% 32% 30% -29% -47% 31% 24% 24% -12% -22%
51 35 39 15 28 1 14 19 38 30 41 48 42
EPS in Rs 4.77 3.24 3.60 1.40 2.58 0.13 1.28 1.74 3.46 2.70 3.64 4.21 3.72
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
273 288 288 343 502 529 811 1,074 1,284 1,129 896 1,676
204 208 218 269 408 394 618 770 917 822 631 1,270
Operating Profit 69 80 70 73 93 134 193 304 367 307 265 405
OPM % 25% 28% 24% 21% 19% 25% 24% 28% 29% 27% 30% 24%
5 8 11 6 19 11 26 7 2 26 13 20
Interest 14 21 21 15 24 45 69 31 62 87 107 139
Depreciation 10 13 15 18 23 29 52 60 66 72 91 115
Profit before tax 50 54 45 48 66 71 99 220 242 174 81 171
Tax % 28% 21% 22% 19% 24% 26% 30% 32% 30% 32% 10% 6%
36 43 35 39 50 53 70 151 169 117 73 161
EPS in Rs 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.68 10.68 6.61 14.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 7% 7% 16% 12% 11% 11%
Compounded Sales Growth
10 Years: 19%
5 Years: 16%
3 Years: 9%
TTM: 87%
Compounded Profit Growth
10 Years: 14%
5 Years: 18%
3 Years: -1%
TTM: 122%
Stock Price CAGR
10 Years: %
5 Years: 12%
3 Years: 7%
1 Year: 13%
Return on Equity
10 Years: 6%
5 Years: 6%
3 Years: 4%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 50 50 50 50 50 50 100 100 107 110 110 114
Reserves 58 97 194 382 432 515 1,473 1,624 2,252 2,627 2,695 3,121
144 279 318 449 687 846 423 836 822 1,067 1,323 1,574
51 55 70 97 145 252 300 325 388 547 752 1,089
Total Liabilities 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,881 5,898
145 259 313 379 682 978 1,116 1,203 1,240 1,277 1,849 2,537
CWIP 21 64 88 250 183 101 42 43 113 579 206 68
Investments 2 2 2 2 0 0 0 148 158 159 159 0
134 157 230 347 449 583 1,137 1,492 2,057 2,336 2,667 3,293
Total Assets 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351 4,881 5,898

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
68 69 17 -8 42 95 1 -171 244 22 -65 274
-88 -168 -93 -247 -261 -178 -192 -412 -478 -362 -286 -656
9 100 73 254 209 102 416 384 376 398 192 356
Net Cash Flow -10 0 -3 -0 -9 19 224 -199 142 58 -160 -26
Free Cash Flow -18 -100 -76 -254 -216 -85 -144 -318 37 -602 -372 -169
CFO/OP 99% 86% 24% -10% 59% 77% 9% -45% 81% 17% -19% 73%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 36 28 71 94 88 89 92 95 106 176 266 200
Inventory Days 158 211 305 411 277 513 528 849 626 849 1,553 543
Days Payable 92 94 156 148 105 225 213 223 202 332 631 335
Cash Conversion Cycle 101 144 220 358 260 378 407 721 530 692 1,188 408
Working Capital Days 86 113 79 88 55 21 168 222 177 162 218 125
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11% 7% 5% 7%

Insights

In beta
Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Manufacturing Units
Number

Log in to view insights

Please log in to see hidden values.

Login
Installed Production Capacity
MTPA
Number of Commercialized Molecules
Number
Number of Customers (MNCs)
Number
Molecules in R&D Pipeline
Number
Tanfac Industries - Hydrofluoric Acid (HF) Capacity
MTPA
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
60.77% 60.73% 61.41% 61.26% 61.23% 61.23% 61.19% 61.19% 61.19% 59.07% 59.07% 59.07%
9.79% 10.26% 9.13% 8.07% 7.14% 7.00% 7.46% 6.47% 4.94% 7.63% 7.60% 6.91%
3.74% 1.76% 2.51% 2.56% 2.56% 2.30% 2.32% 2.25% 2.24% 1.37% 0.41% 0.35%
25.71% 27.25% 26.96% 28.10% 29.06% 29.47% 29.06% 30.11% 31.65% 31.93% 32.89% 33.65%
No. of Shareholders 61,50461,12960,08957,62362,21863,86660,93857,47847,71148,78547,46943,475

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls